Other
Vessel Occlusion
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Vessel Occlusion is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Recruiting1 · 33%
Completed1 · 33%
Not yet recruiting1 · 33%
Clinical Trials
Trial Activity
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
Recruiting·—·Phase 2/3·NCT07302854·382 enrolled
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion： A Multicenter Prospective Randomized Controlled Clinical Trial
Not yet recruiting·TThe First Affiliated Hospital with Nanjing Medical University·Phase 3·NCT07668323·306 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)